Vaxxilon Deutschland GmbH - Firma in Berlin

News
- Overview
- Hot Topics
  - Digital infrastructure / 5G campus network
- News
- Events / Calendar
  - Adlershof Thesis Award
  - Long Night of Sciences Berlin
- Photos / Flyer / Downloads
  - Magazine archive
- Adlershof Journal
- Editorial Staff
Directory / Directions
- Science City in numbers
- Companies / Institutes
  - Newcomers
- Direction / Maps
Science / Technology
- Overview
- Technology Centres
- Start-Ups
  - A² Accelerator Programme
  - Adlershof Founder’s Lab
- Humboldt-University
  - Services for Students
- Non-university Research
- Schoollabs
- Networks / Management
  - Campus Club Adlershof
TV / Media
- TV and Movie Production
- Media Services / Companies
- News and Events
- Filming Locations
- Costume Hire
- GDR Film Archive
- Tickets / Booking
Real Estate
- Overview
- Real Estate Rent
  - Office Space / Workspace / Laboratories
- Real Estate Offers
  - Commercial Properties
- Coworking Space IM.PULS
- Residential
- Construction
Services
- Overview
- Gastronomy / Sport / Culture / Shopping
- Jobs / Market
- Social and Healthcare Facilities
- Startup Services
- WISTA-Business Services
- Event Services / Guided Tours / Hotels
- Facility Management
- Downloads / Photos / Videos
- Jobs for Refugees
Vicinity
- Overview
- History
- Nature Park
- Technology Park
- Trail of Thoughts
- Login
- Search

WISTA Sites
- WISTA Home
- Adlershof
- Charlottenburg
- Dahlem
- Marzahn
- Zukunftsorte

Login
- DE
- EN

Suche
Navigation
Inhalt
Sitemap

Companies / Institutes

Vaxxilon Deutschland GmbH

Magnusstrasse 11, 12489 Berlin

View address on Google Maps

+49 30 6392-4276

@ www.vaxxilon.com

Director

Dr. Claney L. Pereira

Focus

Vaxxilon is focused on the discovery and development of innovative synthetic carbohydrate vaccines.

Competence Fields

Category

Services
Research and Development
Production: Materials

News

Targeting global public health scourges
Adlershof-based companies develop affordable vaccines, better diagnostics, and personalised therapies

Algae slicks and sugar-based vaccines: Biotech in Adlershof

The development of the Science and Technology Park Berlin Adlershof was and is co-financed by the European Union namely by EFRE. This concerns infrastructure development like construction of technology centres. Furthermore EFRE is used for international projects.

Member of:
IASP
BVIZ